DEA vs SBAC

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 07, 2026

DEA

50.8
AI Score
VS
SBAC Wins

SBAC

52.7
AI Score

Investment Advisor Scores

DEA

51score
Recommendation
HOLD

SBAC

53score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric DEA SBAC Winner
Revenue 33.86M 1.42B SBAC
Net Income 942,000 383.61M SBAC
Net Margin 2.8% 27.0% SBAC
Operating Income 15.49M 694.71M SBAC
ROE 0.1% -8.3% DEA
ROA 0.1% 3.3% SBAC
Total Assets 1.37B 11.74B SBAC
Cash 6.55M 327.05M SBAC
Debt/Equity 0.82 -2.75 SBAC

Relative Price Performance (Last 90 Days)

DEA 1M: +0.8% · 3M: +7.1% SBAC 1M: +0.8% · 3M: -15.8%

Current Technical Phase

DEA

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (2.8% over 20 days), RSI 51

RSI (14): 50.6 · Price: $24.96

SBAC

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 51

RSI (14): 50.7 · Price: $184.03

Fundamentals Snapshot

Metric DEA SBAC
Market Cap
Forward P/E 83.2 22.5
Trailing P/E 131.0 20.3
Revenue (TTM)
Revenue Growth 0.1% 0.0%
Gross Margin 0.7% 0.7%
Operating Margin 0.3% 0.5%
EPS 0.19 8.80
Dividend Yield 0.07% 0.03%

Frequently Asked Questions

Based on our detailed analysis, SBAC is currently the stronger investment candidate, winning 8 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.